Statistics
Total Visits
Views | |
---|---|
Phase II single arm open label multicentre clinical trial to evaluate the efficacy and side effects of a combination of gefitinib and methotrexate to treat tubal ectopic pregnancies (GEM II): study protocol | 87 |
Phase II single arm open label multicentre clinical trial to evaluate the efficacy and side effects of a combination of gefitinib and methotrexate to treat tubal ectopic pregnancies (GEM II): study protocol | 41 |
Total Visits per Month
October 2023 | November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | |
---|---|---|---|---|---|---|---|
Phase II single arm open label multicentre clinical trial to evaluate the efficacy and side effects of a combination of gefitinib and methotrexate to treat tubal ectopic pregnancies (GEM II): study protocol | 0 | 5 | 0 | 2 | 0 | 4 | 3 |
File Downloads
Views | |
---|---|
hdl_111749.pdf(legacy) | 54 |
hdl_111749.pdf | 51 |
Top Country Views
Views | |
---|---|
United States | 58 |
Germany | 13 |
China | 12 |
Finland | 10 |
Netherlands | 8 |
Vietnam | 8 |
Australia | 3 |
France | 2 |
Sweden | 2 |
Estonia | 1 |
Top City Views
Views | |
---|---|
Ashburn | 18 |
Helsinki | 10 |
Fairfield | 9 |
Hanoi | 8 |
Rotterdam | 8 |
San Ramon | 8 |
Beijing | 5 |
Des Moines | 4 |
Zhengzhou | 4 |
Cambridge | 3 |